Skip to Content
MilliporeSigma
All Photos(1)

Documents

56921

Millipore

Strep B ChromoSelect Selective Agar Base

NutriSelect® Plus, suitable for microbiology

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41171606
NACRES:
NA.85

sterility

non-sterile

Quality Level

form

powder

shelf life

limited shelf life, expiry date on the label

composition

agar, 15.0 g/L
buffers, 2.5 g/L
chromogenic mixture, 2.54 g/L
protein hydrolysate, 17.5 g/L
selective agents, 0.110 g/L

manufacturer/tradename

NutriSelect® Plus

final pH

7.3±0.2 (25 °C)

application(s)

clinical testing
veterinary

microbiology

storage temp.

2-8°C

suitability

Streptococcus spp.

Related Categories

Application

Strep B ChromoSelect Selective Agar Base is recommended for selective isolation of Group B streptococci.

Preparation Note

Suspend 37.65 grams in 1000 ml distilled water. Heat to boiling to dissolve the medium completely. DO NOT AUTOCLAVE. Cool to 45-50°C and aseptically add the rehydrated contents of one vial of Strep B ChromoSelect Selective Supplement (Cat. No. 92650). Mix well and pour in sterile Petri plates.

Footnote

We offer two media types: the superior granulated GranuCult® and the cost-efficient powdered NutriSelect® culture media, depending on your needs.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.

Legal Information

GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 45(RR-7), 1-24 (1996-05-31)
Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS infections can be prevented through the use of intrapartum antimicrobial prophylaxis in women who are at increased risk for transmitting the infection to their newborns. However
B F Anthony et al.
The Journal of infectious diseases, 137(5), 524-530 (1978-05-01)
A longitudinal, three-year study of the epidemiology of group B Streptococcus was conducted with repeated (four to 11) observations of 382 patients followed through pregnancy, delivery, and the postpartum period. Group B streptococci (2.3% of which were nonhemolytic) were isolated
Murray, P.R., E.J. Baron, J.H. Jorgensen, M.A. Pfaller, and R. H. Yolken (Eds.)
Manual of Clinical Microbiology (2003)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service